Editorial Advisory Board Member, Harvard Health Publishing Compounding pharmacies have been in the news a lot lately, thanks to reports of some of them marketing and selling in-demand weight loss drugs such as semaglutide (Wegovy)
Additionally, millions around the world have started using these medications to assist in [their] weight loss goals. This is not the first research to examine a link between the use of GLP-1 agonists and potential gastrointestinal problems
These findings suggest that GLP-1 agonists be used in patients who would benefit from weight loss in real-world settings, White said
Q: What does VARS stand for
This regulatory approach creates elevated risk when using dietary supplements, which WADA does not regulate or approve, and which numerous scientific studies have shown may contain undeclared drugs
Can be combined with other weight loss treatments for added effectiveness